Section DHS 153.08 - Standards for comprehensive treatment centers(1) COMPLIANCE. A comprehensive hemophilia treatment center shall comply with the standards in this section.(2) STAFFING. A comprehensive hemophilia treatment center shall have the following staff: (a)A physician director.1. The physician director shall be a physician licensed in Wisconsin and certified by the American board of internal medicine or American board of pediatrics or equivalent certifying body, with specialized training in hematology.2. The responsibilities of the physician director shall include organizing and coordinating the administrative functions of the comprehensive hemophilia treatment center; delegating duties and establishing a formal means of accountability for those involved in patient care; participating in the development, negotiation and implementation of agreements into which the center may enter; maintaining records and submitting any required reports to the department; providing medical supervision; and developing written home care training policies and procedures and supervising their implementation.(b)Specialists on staff.1. The center shall have a multidisciplinary staff which shall include a hematologist, internist, pediatrician, orthopedic surgeon, oral surgeon or dentist, radiologist, physical therapist, registered nurse, social worker and financial counselor.2. The multidisciplinary staff and the physician director shall develop patient maintenance programs and shall provide services, including the training of patients in home care, access to the necessary psychosocial evaluations and referrals and assistance in securing reimbursement.(c)Specialists available. The center shall arrange for the availability of a nutritionist, psychiatrist or psychologist, and an educational, vocational or rehabilitation counselor, as needed.(3) FACILITIES. A comprehensive hemophilia treatment center shall be approved under ss. 50.32 to 50.39, Stats., and ch. DHS 124, and shall meet all of the requirements of s. 1861 (e) of the Social Security Act of 1935, as amended, including having an agreement to participate in the federal Medicare program.(4) SERVICES. A comprehensive hemophilia treatment center shall provide all of the following: (a) Training in home care self-infusion techniques for hemophilia patients and their parents or guardians. This training shall include instructing the patient and whoever assists the patient in how to use the products, equipment and supplies necessary for home care treatment;(b) A written maintenance program for each home care hemophilia patient. The maintenance program shall be reviewed by the multidisciplinary staff every 6 months and shall accompany the patient in inter-facility transfer;(c) Blood products and home care supplies, including plasma factor concentrate, cryoprecipitate and fresh frozen plasma. Blood products and supplies may be provided directly or under agreement;(d) Emergency medical services 24-hours a day and 7 days a week for home care patients who need medical services; and(e) Services of a laboratory certified under 42 CFR 493 capable of testing for plasma factor deficiency and for the presence of inhibitors to one or more clotting factors. Laboratory services may be provided directly or under agreement. Note: The department of health services regulates laboratories testing human specimens under agreement with the federal department of health and human services for compliance with 42 CFR 493.
(5) AVAILABILITY OF A GRIEVANCE MECHANISM FOR PATIENTS. A center shall have a written grievance procedure and shall provide a copy to each patient. A patient shall be permitted to file a grievance.(6) DOCUMENTATION. All comprehensive hemophilia treatment centers and other providers shall maintain the following records: (a) Agreements with individual patients regarding home care, as described under s. DHS 153.03(3);(b) Agreements with persons or organizations for payment which may be made, directly or indirectly, by the hemophilia home care program;(c) Billings and records which are the subject of the billings, as are necessary to disclose fully the nature and extent of the billings; and(d) Any and all prescriptions necessary to disclose the nature and extent of blood products and supplies provided and billed for under the program.Wis. Admin. Code Department of Health Services DHS 153.08
Cr. Register, December, 1994, No. 468, eff. 1-1-95; corrections in (3) made under s. 13.92(4) (b) 7, Stats., Register January 2009 No. 637; correction in (4) (e) made under s. 13.92(4) (b) 7, Stats., Register July 2011 No. 667.